In 2008, Toyama Chemical, a major pharmaceutical developer, became a Fujifilm group company. This acquisition gives Fujifilm the opportunity to collaborate on and accelerate the discovery of new drugs. Toyama Chemical's strong research & development capabilities will benefit from synergy with Fujifilm's vast portfolio of unique materials and technologies, supported by a global network and strong financial foundation. For example, a photographic dye originally synthesized by Fujifilm shows potential as an antitumor drug.